Möglingen, February 23, 2023. Parnassia Groep, headquartered in Den Haag, has commissioned USU with the Liferay-based operation, further development, and migration to the latest Liferay version DXP 7.4 for its roughly 30 websites. Parnassia Groep is the largest Dutch provider of medical and social support services for adults with mental illnesses of all kinds.
After the start of the project, USU will assume operational responsibility for the AWS-based Liferay installation starting in April 2023. The contract will initially run until the end of 2024 with extension options and covers the following aspects:
USU emerged successful thanks to its expertise as a certified Liferay Platinum Partner with the best technical concept, experience in application management, and numerous references from successfully implemented customer projects.
This press release is available at https://www.usu.com.
About USU
As a leading provider of software and services for IT and customer service management, USU enables companies to master the demands of today’s digital world. Global organizations use our solutions to cut costs, become more agile and reduce risks – with smarter services, simpler workflows and better collaboration. With more than 45 years of experience and locations worldwide, the USU team brings customers into the future.
Further information: https://www.usu.com
Contact
USU Software AG
Corporate Communications
Dr. Thomas Gerick
Tel.: +49 (0) 71 41 – 48 67 440
E-Mail: thomas.gerick@usu.com
USU Software AG
Investor Relations
Falk Sorge
Tel.: +49 (0) 71 41 – 48 67 351
E-Mail: falk.sorge@usu.com
Source: RealWire
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…